Abstract
A Vanderbilt team has found that knocking out the tyrosine kinase Tie1 on vascular endothelial cells in mice decreases the formation of atherosclerotic plaques. The findings could represent a new indication for sanofi-aventis, which has licensed at least two therapies targeting TIE proteins in cancer and wound healing.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
